Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

Diagnostic Microbiology and Infectious Disease

Volumn 29, Issue 2, 1997, Pages 95-102

  Jones, Ronald N ^a   Marshall, Steven A ^a   Pfaller, Michael A ^a   Wilke, Werner W ^a   Hollis, Richard J ^a   Erwin, Meridith E ^a   Edmond, Michael B ^b   Wenzel, Richard P ^b  

^a UNIVERSITY OF IOWA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; DIAGNOSTIC ACCURACY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; GENOTYPE; HOSPITAL INFECTION; LABORATORY TEST; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES DIFFERENCE; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; UNITED STATES;

EID: 0030728837     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00115-6     Document Type: Article

References (26)

1. Blanchard MM, Taillon-Miller P, Nowotny P, Nowotny V (1993) PCR buffer optimization with uniform temperature regimen to facilitate automation. PCR Method Appl 2:234-240.
2. Centers for Disease Control (1993) Nosocomial enterococci resistant to vancomycin: United States, 1989-1993: National Nosocomial Infection Surveillance. MMWR 42: 597-599.
3. Centers for Disease Control and Prevention (1995) Recommendations for presenting the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44(RR-12):1-13.
4. Cercenado E, Ünal S, Eliopoulos CT, Rubin LG, Isenberg HD, Moellering Jr RC, Eliopoulos GM (1995) Characterization of vancomycin resistance in Enterococcus durans. J Antimicrob Chemother 36:821-825.
5. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC (1993) Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 37:2311-2317.
6. Cormican MG, Jones RN (1996) The role of teicoplanin in contemporary therapy of enterococcal infection. Chemother J 5:174-179.
7. Dutka-Malen S, Evers S, Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33:24-27.
8. Emori TG, Gaynes RP (1993) An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 6:428-442.
9. Facklam RR, Collins MD (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27:731-734.
10. Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, Thornsberry C, Enterococcal Study Group, Jarvis WR, Tenover FC (1992) Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 30:2373-2378.
11. Jones RN, Erwin ME, Anderson SC (1995a) Emerging multiply resistant enterococci among clinical isolates. II. Validation of the Etest to recognize glycopeptideresistant strains. Diagn Microbiol Infect Dis 21:95-100.
12. Jones RN, Sader HS, Erwin ME, Anderson SC, the Enterococcus Study Group (1995b) Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 21:85-93.
13. Jones RN, Kehrberg EN, Erwin ME, Anderson SC, the Fluoroquinolone Resistance Surveillance Group (1994) Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistance: Real or perceived? Diagn Microbiol Infect Dis 19:203-215.
14. LeClercq R, Derlot E, Weber M, Duval J, Courvalin P (1989) Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 33:10-15.
15. LeClercq R, Courvalin P (1997) Resistance to glycopeptides in enterococci. Clin Infect Dis 24:545-556.
16. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Approval standard M7-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA: NCCLS.
17. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard 6th Information Supplement M100-S6. Villanova, PA: NCCLS.
18. Pfaller MA, Wendt C, Hollis RJ, Wenzel RP, Fritschel SJ, Neubauer JJ, Herwaldt LA (1996) Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent Gram-negative bacteremia. Diagn Microbiol Infect Dis 25:1-8.
19. Rao GG, Morris DJ, George RC, Woodford N (1992) Vancomycin-resistant enterococci in a district general hospital. Lancet 340:1471-1472.
20. Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ (1990) Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 28:435-437.
21. Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN (1994) Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 32:2840-2842.
22. Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J (1989) High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 103:173-181.
23. Weinstein M, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB (1997) The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584-602.
24. Wilke WW, Sutton LD, Jones RN (1995) Automation of polymerase chain reaction tests to achieve acceptable contamination rates. Clin Chem 41:622-623.
25. Wilke WW, Marshall SA, Coffman SL, Pfaller MA, Edmond MB, Wenzel RP, Jones RN (1997) Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 28:43-49.
26. Woodford N, Johnson AP, Morrison D, Speller DCE (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev 8:585-615.